Swift Biosciences is developing a suite of technology platforms for advanced sequencing applications. These platforms are based on proprietary protocols and reagents invented by Swift. Applications under development include:

• Multiplexed, low-bias, targeted selection
• Highly sensitive, allele-specific NGS
• Fragment library creation
• Indexing/bar coding

All of the applications share the features of being fast, easy and compatible with existing NGS instruments.